Q&A: FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer’s Drug Approval
Similar Posts
New Leadership for the HIMSS North America Board
As the new HIMSS North America Board began its year on July 1, the vision of improving health with…
Smartphones Key to Unlocking Frictionless Patient Registration
Writen by Daniel Cidon, Chief Technology Officer at NextGate Since the beginning of healthcare’s digital revolution, organizations have been…
FINN’s Kristie Kuhl Takes Global Health Helm,
Prepares for Next Wave of GrowthAppointment Signals Health Practice Transformation and Will Impact Agency-Wide Growth as FINN Works to Advance Industry Efforts Toward a…
Understand your body better with the new ECG App from Garmin
FDA-cleared and clinically-validated app lets Venu 2 Plus customers record an ECG and check for signs of atrial fibrillation…
